CTLA4 and neoplasm: James P. Allison worked in the development of an anti-CTLA-4 blocking antibody to counteract tumor-induced immunosuppression [15], and Tasuku Honjo’s work played a critical role in the development of the anti-PD-1 blocking antibody [16].